Website profile

Pharmaceutical Executive

Master the Science of Success through aspirational coverage for executive-level decisions, leadership, management, strategy and commercialization professionals.

  • 913articles · 365d
  • 15+ hour agolatest article
  • Sep 14, 2025earliest in window
  • 95%with images
  • 285avg words
articles per day
Categories
  • Medical 573
  • Business & Industrial 538
  • Economy, Business & Finance 451
  • Health & Wellness 337
  • Health 267
  • Finance & Business 254
  • Science & Technology 156
  • Science & Nature 42

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

PharmExec
pharmexec.com > view > boards-ai-500-years-experience-life-sciences-takeaways-board-forum

Boards, AI, and 500 Years of Experience in Life Sciences: Takeaways from the 2026 Life Sciences Board Forum

15+ hour, 58+ min ago   (92+ words) This June, ten of the life sciences industry’s most respected board members came to New York for Accenture’s second annual Life Sciences Board Forum for something this industr... Ten life sciences board directors on AI's three hardest questions: developing the…...

PharmExec
pharmexec.com > view > zeno-paradox-orphan-product-access-future-unmet-need

Zeno???s Paradox, Orphan Product Access and the Future of Unmet Need

2+ day, 16+ hour ago   (364+ words) Unmet need is likely a new battlefield impacting prior authorization. CMS ACCESS Model: Changing the Landscape of Disease Management Orphan Product Risk Contracting Future Phase III Trial Planning: Payer Point of View Zeno’s paradox is a riddle about motion and…...

PharmExec
pharmexec.com > view > claimguardrx-ai-detects-counters-diversion-tactics

How ClaimGuardRx's Purpose-Built AI Detects and Counters Diversion Tactics

4+ day, 57+ min ago   (124+ words) Pharmaceutical Executive Sponsored by Paysign Bryan Dennison, Senior Vice President of Sales and Product at Paysign, explains the technical foundation of ClaimGuardRx, a proprietary large language model (LLM) trained specifically on patient affordability claim patterns rather than adapted from a general-purpose…...

Pharmaceutical Executive
pharmexec.com > shorts > unlocking-future-real-world-data-research

Unlocking the Future of Real-World Data & Research | PharmExec

4+ day, 4+ hour ago   (40+ words) Unlocking the Future of Real-World Data & Research Pharmaceutical Executive Pharmaceutical Executive Daily: Moonwalk Biosciences' $70 Million Series B Trusted Research Environments Are Reshaping Real-World Data Access: Q&A with Mark Cziraky FDA Approves Zanvastro for Alexander Disease in Pediatrics & Adults...

PharmExec
pharmexec.com > view > daily-moonwalk-biosciences-70-million-series-b

Pharmaceutical Executive Daily: Moonwalk Biosciences' $70 Million Series B

4+ day, 14+ hour ago   (83+ words) Moonwalk Biosciences' $70 Million Series B | PharmExec Pharmaceutical Executive Aptar Pharma and Aceso Therapeutics team up to advance an inhaled cystic fibrosis therapy, Moonwalk Biosciences raises a $70 million Series B for its fat-targeted obesity platform, and Sebastian Arana of MilliporeSigma talks…...

PharmExec
pharmexec.com > view > trusted-research-environments-reshaping-real-world-data-access

Trusted Research Environments Are Reshaping Real-World Data Access: Q&A with Mark Cziraky

6+ day, 4+ hour ago   (497+ words) Pharmaceutical Executive The pharma and biotech industries run on data, especially on the R&D side Data is one of the most valuable assets, but it can also cause some of the biggest headaches Due to the wide array of…...

PharmExec
pharmexec.com > view > why-ai-trust-comes-down-one-equation-parth-khanna

Why AI Trust Comes Down to One Equation: Q&A with Parth Khanna

1+ week, 5+ day ago   (400+ words) ACTO’s CEO on AI trust, the future of the sales rep, and why human intelligence plus empathetic agents is the winning formula. Over recent years, the pharmaceutical industry has generally embraced AI. Due the nature of the technology, various companies…...

Google News
pharmexec.com > view > industry-shift-rwd

The Industry???s Shift on RWD

1+ week, 5+ day ago   (247+ words) Carelon Research's Mark Cziraky on why the industry's need for deeper, linked data is driving a shift toward trusted research environments. The pharma and biotech industries run on data, especially on the R&D side. Data is one of the…...

PharmExec
pharmexec.com > view > ai-implementations-that-produce-real-business-value

The AI Implementations That Produce Real Business Value

2+ week, 4+ day ago   (296+ words) Pharmaceutical Executive Over recent years, the pharmaceutical industry has generally embraced AI Due the nature of the technology, various companies has implemented it across multiple sectors Now, the question that everyone is asking is: where is AI having an actual…...

PharmExec
pharmexec.com > view > infrastructure-first-a-framework-for-scaling-ai-in-life-sciences

Infrastructure First: A Framework for Scaling AI in Life Sciences

2+ week, 5+ day ago   (219+ words) You've seen it before: an AI pilot that works in testing, then stalls the moment someone asks you to reproduce the result. The cause usually isn't the model—it's what wasn't built around it. Komodo Health built this framework from…...